HomePTGX • NASDAQ
add
Protagonist Therapeutics Inc
Previous close
$41.65
Day range
$42.40 - $47.50
Year range
$16.80 - $48.89
Market cap
2.74B USD
Avg Volume
655.81K
P/E ratio
17.36
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.68M | — |
Operating expense | 46.13M | 20.36% |
Net income | -33.21M | 2.62% |
Net profit margin | -710.37 | — |
Earnings per share | -0.54 | 6.90% |
EBITDA | -41.22M | -8.25% |
Effective tax rate | 1.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 468.72M | 46.13% |
Total assets | 603.86M | 82.98% |
Total liabilities | 71.94M | 158.16% |
Total equity | 531.92M | — |
Shares outstanding | 59.60M | — |
Price to book | 4.66 | — |
Return on assets | -17.01% | — |
Return on capital | -18.93% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -33.21M | 2.62% |
Cash from operations | -27.86M | -4.70% |
Cash from investing | -208.71M | -1,439.27% |
Cash from financing | 12.05M | -65.88% |
Net change in cash | -224.52M | -4,524.55% |
Free cash flow | -14.04M | 7.92% |
About
Founded
2006
Headquarters
Website
Employees
126
